mammaprint, a microarray gene expression analysis (Agendia BV)
Structured Review
Mammaprint, A Microarray Gene Expression Analysis, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+gene+expression+analysis/mammaprint+assay/pm39602125-66-0-9
Average 90 stars, based on 1 article reviews
Images
Related Articles
Expressing:Article Title: Customized assays for personalized cancer monitoring Article Snippet: .. For example, the other:Article Title: Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial Article Snippet: 14 Using the expression data generated, Article Title: Genetic and clinical landscape of ER + /PR- breast cancer in China Article Snippet: Genecast Biotechnology has obtained the authorization of MammaPrint® and Article Title: Do circulating neutrophil extracellular traps predict recurrence in early breast cancer? Article Snippet: Genomic signatures such as the Oncotype Dx recurrence score (RS) (Genomic Health), PAM50-based Prosigna risk of recurrence (ROR) (NanoString), Breast Cancer Index (BCI) (bioTheranostics), EndoPredict (EPclin) (Myriad Genetics), and Article Title: Genetic and clinical landscape of ER + /PR- breast cancer in China. Article Snippet: Genecast Biotechnology has obtained the authorization of MammaPrint® and Gene Expression:Article Title: MammaPrint Genomic Assay Providing Prognostic Information in Early Breast Cancer: 10-Year Follow-Up From a Retrospective German Breast Cancer Registry Analysis Article Snippet: .. Introduction: Gene expression assays, such as the MammaPrint® (Agendia, Amsterdam, the Netherlands) Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. Microarray:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. Formalin-fixed Paraffin-Embedded:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. Amplification:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. Labeling:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. Diagnostic Assay:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. |

